Arkolith/Insider Trading/EKSO/Form 4

Sherman Steven

CEO & Chairman, DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Jul 25, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2022Sell(S)6K$1.75$10K669K
Jul 21, 2022Option exercise(M)16K—$0675K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2022Option exercise(M)16K—$094K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001549084-22-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML